Feasibility of mean platelet volume as a biomarker for chronic obstructive pulmonary disease: A systematic review and meta-analysis

被引:4
作者
Ma, Yiming [1 ]
Zong, Dandan [1 ]
Zhan, Zijie [1 ]
Li, Herui [1 ]
Dai, Zhongshang [1 ]
Cui, Yanan [1 ]
Luo, Lijuan [1 ]
Zeng, Zihang [1 ]
He, Chenjie [1 ]
Chen, Yan [1 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Resp & Crit Care Med, Changsha 410011, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
Chronic obstructive pulmonary disease; mean platelet volume; biomarker; inflammation; acute exacerbations; meta-analysis; TO-LYMPHOCYTE RATIO; INFLAMMATORY MARKER; ACUTE EXACERBATION; COPD; COMORBIDITY; ACTIVATION; COUNT; MPV;
D O I
10.1177/0300060519887886
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective To evaluate the feasibility of mean platelet volume (MPV) as a biomarker for chronic obstructive pulmonary disease (COPD). Methods A systematic search for studies published up to March 2019 was performed in the PubMed and Web of Science databases. Three independent investigators screened the titles and abstracts of including studies according to eligibility criteria. The Newcastle-Ottawa Scale was used to assess the quality of eligible studies, and statistical analyses were performed using Review Manager version 5.3. Results A total of eight studies with 1230 COPD patients and 443 healthy controls were included in our meta-analysis. No significant differences in MPV level were identified in pairwise comparisons of the acute exacerbations of COPD (AECOPD), stable COPD, and control groups. Furthermore, no significant correlation was observed between MPV level and systemic inflammatory biomarkers. Conclusions MPV does not appear to represent a suitable biomarker of disease phase or inflammatory burden in COPD. However, future large-scale studies should be performed to further investigate the relationship between MPV and COPD.
引用
收藏
页码:5937 / 5949
页数:13
相关论文
共 35 条
[1]   The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation [J].
Agapakis, Dimitris I. ;
Massa, Eleni V. ;
Hantzis, Ioannis ;
Maraslis, Stefanos ;
Alexiou, Evagelos ;
Imprialos, Konstantinos P. ;
Damianidou, Maria ;
Satsoglou, Emilios .
RESPIRATORY CARE, 2016, 61 (01) :44-49
[2]   Mean Platelet Volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity [J].
Aktas, Gulali ;
Kocak, Mehmet Z. ;
Duman, Tuba T. ;
Erkus, Edip ;
Atak, Burcin M. ;
Sit, Mustafa ;
Savli, Haluk .
BALI MEDICAL JOURNAL, 2018, 7 (03) :650-653
[3]   Mean platelet volume can be affected by many factors and should be assessed together with other inflammatory markers [J].
Balta, Sevket ;
Demirkol, Sait ;
Unlu, Murat ;
Arslan, Zekeriya .
PLATELETS, 2014, 25 (05) :388-389
[4]   Platelet size: Measurement, physiology and vascular disease [J].
Bath, PMW ;
Butterworth, RJ .
BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (02) :157-161
[5]   Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease [J].
Biljak, Vanja Radisic ;
Pancirov, Dolores ;
Cepelak, Ivana ;
Popovic-Grle, Sanja ;
Stjepanovic, Gordana ;
Grubisic, Tihana Zanic .
PLATELETS, 2011, 22 (06) :466-470
[6]   Seeing the Fisher Z-transformation [J].
Bond, CF ;
Richardson, K .
PSYCHOMETRIKA, 2004, 69 (02) :291-303
[7]   Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease [J].
Celli, Bartolome R. ;
Locantore, Nicholas ;
Yates, Julie ;
Tal-Singer, Ruth ;
Miller, Bruce E. ;
Bakke, Per ;
Calverley, Peter ;
Coxson, Harvey ;
Crim, Courtney ;
Edwards, Lisa D. ;
Lomas, David A. ;
Duvoix, Annelyse ;
MacNee, William ;
Rennard, Stephen ;
Silverman, Edwin ;
Vestbo, Jorgen ;
Wouters, Emiel ;
Agusti, Alvar .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (10) :1065-1072
[8]   Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis [J].
Chen, Wenjia ;
Thomas, Jamie ;
Sadatsafavi, Mohsen ;
FitzGerald, J. Mark .
LANCET RESPIRATORY MEDICINE, 2015, 3 (08) :631-639
[9]   Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis [J].
Chu, S. G. ;
Becker, R. C. ;
Berger, P. B. ;
Bhatt, D. L. ;
Eikelboom, J. W. ;
Konkle, B. ;
Mohler, E. R. ;
Reilly, M. P. ;
Berger, J. S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (01) :148-156
[10]   Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction [J].
Chung, K. F. ;
Adcock, I. M. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) :1334-1356